Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1997-11-25
|
pubmed:abstractText |
To evaluate the ecological disturbances of peroral vancomycin administration following cephalosporin administration, 20 healthy volunteers received cefuroxime axetil tablets (250 mg) perorally twice a day for 1 week, and 10 of these volunteers subsequently received vancomycin capsules (125 mg) perorally four times daily for 7 days. The concentration of vancomycin in feces after 1 week of vancomycin administration was high (mean +/- SD, 520 +/- 197 mg/kg), which correlated with the ecological disturbances noted in the vancomycin recipients. Vancomycin administration resulted in a rapid decrease in the numbers of intestinal Enterococcus faecium, Enterococcus faecalis, and Enterococcus durans (P < or = .05), while there was a significant emergence of motile enterococci with decreased susceptibility to vancomycin (Enterococcus gallinarum and Enterococcus casseliflavus; minimum inhibitory concentration, 4-16 mg/L) (P < or = .01). Because of vancomycin administration, there was also a significant overgrowth of vancomycin-resistant Pediococcus species and lactobacilli as well as of Klebsiella species, Citrobacter species, and Enterobacter species (P < or = .01). The numbers of bifidobacteria and Bacteroides species were significantly reduced during vancomycin administration. None of the enterococcal strains carried vanA or vanB. Twenty-two of the 27 motile enterococci carried the vanC-1 gene specific for E. gallinarum, whereas five strains carried the vanC-2(C-3) gene, thus implicating that they were E. casseliflavus or Enterococcus flavescens.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cefuroxime,
http://linkedlifedata.com/resource/pubmed/chemical/Cephalosporins,
http://linkedlifedata.com/resource/pubmed/chemical/Vancomycin,
http://linkedlifedata.com/resource/pubmed/chemical/cefuroxime axetil
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1058-4838
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
729-32
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9314469-Administration, Oral,
pubmed-meshheading:9314469-Adult,
pubmed-meshheading:9314469-Anti-Bacterial Agents,
pubmed-meshheading:9314469-Cefuroxime,
pubmed-meshheading:9314469-Cephalosporins,
pubmed-meshheading:9314469-Colony Count, Microbial,
pubmed-meshheading:9314469-Drug Resistance, Microbial,
pubmed-meshheading:9314469-Ecosystem,
pubmed-meshheading:9314469-Enterococcus,
pubmed-meshheading:9314469-Feces,
pubmed-meshheading:9314469-Female,
pubmed-meshheading:9314469-Genotype,
pubmed-meshheading:9314469-Gram-Positive Cocci,
pubmed-meshheading:9314469-Humans,
pubmed-meshheading:9314469-Intestines,
pubmed-meshheading:9314469-Male,
pubmed-meshheading:9314469-Middle Aged,
pubmed-meshheading:9314469-Time Factors,
pubmed-meshheading:9314469-Vancomycin
|
pubmed:year |
1997
|
pubmed:articleTitle |
Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy.
|
pubmed:affiliation |
Department of Immunology, Karolinska Institute, Huddinge University Hospital, Sweden.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|